- Home
- RPRX vs BEN Comparison
RPRX vs BEN Comparison
Compare RPRX & BEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- BEN
- Stock Information
- Founded
- RPRX 1996
- BEN 1947
- Country
- RPRX United States
- BEN United States
- Employees
- RPRX N/A
- BEN N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- BEN Investment Managers
- Sector
- RPRX Health Care
- BEN Finance
- Exchange
- RPRX Nasdaq
- BEN Nasdaq
- Market Cap
- RPRX 15.6B
- BEN 12.6B
- IPO Year
- RPRX 2020
- BEN N/A
- Fundamental
- Price
- RPRX $35.15
- BEN $24.37
- Analyst Decision
- RPRX Strong Buy
- BEN Hold
- Analyst Count
- RPRX 3
- BEN 12
- Target Price
- RPRX $45.33
- BEN $22.79
- AVG Volume (30 Days)
- RPRX 3.9M
- BEN 3.4M
- Earning Date
- RPRX 11-05-2025
- BEN 11-03-2025
- Dividend Yield
- RPRX 2.50%
- BEN 5.25%
- EPS Growth
- RPRX 54.86
- BEN N/A
- EPS
- RPRX 2.32
- BEN 0.52
- Revenue
- RPRX $2,305,243,000.00
- BEN $8,638,200,000.00
- Revenue This Year
- RPRX $33.77
- BEN N/A
- Revenue Next Year
- RPRX $4.62
- BEN $4.36
- P/E Ratio
- RPRX $15.12
- BEN $46.51
- Revenue Growth
- RPRX 3.02
- BEN 4.67
- 52 Week Low
- RPRX $24.05
- BEN $16.25
- 52 Week High
- RPRX $38.00
- BEN $26.08
- Technical
- Relative Strength Index (RSI)
- RPRX 40.78
- BEN 42.29
- Support Level
- RPRX $35.97
- BEN $24.18
- Resistance Level
- RPRX $36.94
- BEN $24.86
- Average True Range (ATR)
- RPRX 0.85
- BEN 0.45
- MACD
- RPRX -0.06
- BEN -0.14
- Stochastic Oscillator
- RPRX 33.46
- BEN 10.98
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About BEN Franklin Resources Inc.
Franklin Resources provides investment services for individual and institutional investors. At the end of July 2025, Franklin had $1.617 trillion in managed assets, composed primarily of equity (41%), fixed-income (27%), multi-asset/balanced (11%) funds, alternatives (16%) and money market funds (5%). Distribution tends to be weighted between retail investors (56% of AUM) and institutional accounts (41%), with high-net-worth clients accounting for the remainder. Franklin is one of the more global of the US-based asset managers we cover, with 31% of its assets under management invested in global/international strategies and just as much sourced from clients domiciled outside the United States.